Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Syngene International Ltd

NSE: SYNGENE · BSE: 539268 · Pharmaceuticals & Biotechnology · 38 announcements

Share price
₹360.15
Market cap
₹14,538 Cr
Revenue (annual)
₹3,739 Cr
Net profit (annual)
₹316.7 Cr
P/E (TTM)
65.8×Sector 47.4×
Promoter holding
52.59%-0.09% QoQ
FII holding
11.82%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

20:57 IST NSE
Annual General Meeting

Syngene International Annual General Meeting

Syngene International Limited held its 33rd Annual General Meeting on July 29, 2026. The meeting transacted business including the adoption of financial statements and dividend declaration.

17:57 IST NSE
Annual General Meeting

Syngene International Annual General Meeting

Syngene International will hold its 33rd AGM on July 29, 2026, to approve financials, dividend, and director appointments. The notice includes details on remuneration for new MD & CEO.

22:01 IST NSE
Annual General Meeting

Syngene International Annual General Meeting

Syngene International Limited issued a postal ballot notice to redesignate Ms. Kiran Mazumdar-Shaw as Executive Chairperson. The five-year tenure commences April 2026.

Execution
2026-04-01 to 2031-03-31
22:00 IST BSE
Annual General Meeting

Syngene International Annual General Meeting

Syngene International initiated a postal ballot for appointing Ms. Kiran Mazumdar-Shaw as Executive Chairperson with ₹4 Crore annual remuneration. This leadership transition aims to align with corporate strategy.

Value
₹4.00 Cr
Execution
5 years